Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy

Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy

Although anti-CD38 monoclonal antibodies have improved the prognosis of relapsed/refractory multiple myeloma (RRMM), some patients still experience early relapses with poor outcomes. This present study evaluated the predictive value of FDG PET/CT parameters for RRMM prior to initiating anti-CD38 tre...

Full description

Bibliographic Details
Main Authors: Guillemette Fouquet, Myriam Wartski, Amina Dechmi, Lise Willems, Bénédicte Deau-Fischer, Patricia Franchi, Justine Descroocq, Paul Deschamps, Estelle Blanc-Autran, Jérôme Clerc, Didier Bouscary, Sylvain Barreau, Nicolas Chapuis, Marguerite Vignon, Anne-Ségolène Cottereau
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
myeloma
immunotherapy
anti-CD38
FDG-PET/CT
prognostic factor
focal bone lesion
Online Access:https://www.mdpi.com/2072-6694/13/17/4323

Internet

https://www.mdpi.com/2072-6694/13/17/4323

Similar Items